annual cash & cash equivalents:
$71.33M-$17.06M(-19.30%)Summary
- As of today (June 1, 2025), ARQT annual cash & cash equivalents is $71.33 million, with the most recent change of -$17.06 million (-19.30%) on December 31, 2024.
- During the last 3 years, ARQT annual cash & cash equivalents has fallen by -$25.11 million (-26.04%).
- ARQT annual cash & cash equivalents is now -26.04% below its all-time high of $96.45 million, reached on December 31, 2021.
Performance
ARQT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$53.10M-$18.23M(-25.56%)Summary
- As of today (June 1, 2025), ARQT quarterly cash & cash equivalents is $53.10 million, with the most recent change of -$18.23 million (-25.56%) on March 31, 2025.
- Over the past year, ARQT quarterly cash & cash equivalents has dropped by -$136.99 million (-72.06%).
- ARQT quarterly cash & cash equivalents is now -81.61% below its all-time high of $288.69 million, reached on March 31, 2021.
Performance
ARQT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ARQT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -72.1% |
| 3 y3 years | -26.0% | -23.9% |
| 5 y5 years | +12.6% | -72.2% |
ARQT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.0% | +33.0% | -72.1% | at low |
| 5 y | 5-year | -26.0% | +33.0% | -81.6% | +16.2% |
| alltime | all time | -26.0% | +1987.0% | -81.6% | +129.1% |
ARQT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $53.10M(-25.6%) |
| Dec 2024 | $71.33M(-19.3%) | $71.33M(-47.1%) |
| Sep 2024 | - | $134.85M(+60.0%) |
| Jun 2024 | - | $84.27M(-55.7%) |
| Mar 2024 | - | $190.10M(+115.0%) |
| Dec 2023 | $88.40M(+64.8%) | $88.40M(-17.7%) |
| Sep 2023 | - | $107.47M(+2.2%) |
| Jun 2023 | - | $105.11M(+29.1%) |
| Mar 2023 | - | $81.41M(+51.8%) |
| Dec 2022 | $53.64M | $53.64M(-34.2%) |
| Sep 2022 | - | $81.54M(+32.6%) |
| Jun 2022 | - | $61.51M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $69.80M(-27.6%) |
| Dec 2021 | $96.45M(+48.2%) | $96.45M(+86.3%) |
| Sep 2021 | - | $51.78M(-41.9%) |
| Jun 2021 | - | $89.13M(-69.1%) |
| Mar 2021 | - | $288.69M(+343.6%) |
| Dec 2020 | $65.08M(+2.8%) | $65.08M(+42.4%) |
| Sep 2020 | - | $45.71M(-73.4%) |
| Jun 2020 | - | $171.55M(-10.1%) |
| Mar 2020 | - | $190.89M(+201.4%) |
| Dec 2019 | $63.34M(+60.8%) | $63.34M(+173.3%) |
| Sep 2019 | - | $23.18M(-41.2%) |
| Dec 2018 | $39.39M(+1052.5%) | $39.39M |
| Dec 2017 | $3.42M | - |
FAQ
- What is Arcutis Biotherapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual cash & cash equivalents year-on-year change?
- What is Arcutis Biotherapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly cash & cash equivalents year-on-year change?
What is Arcutis Biotherapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ARQT is $71.33M
What is the all time high annual cash & cash equivalents for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual cash & cash equivalents is $96.45M
What is Arcutis Biotherapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ARQT annual cash & cash equivalents has changed by -$17.06M (-19.30%)
What is Arcutis Biotherapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ARQT is $53.10M
What is the all time high quarterly cash & cash equivalents for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly cash & cash equivalents is $288.69M
What is Arcutis Biotherapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, ARQT quarterly cash & cash equivalents has changed by -$136.99M (-72.06%)